Impact of CD33 and ABCB1 single nucleotide polymorphisms in patients with acute myeloid leukemia and advanced myeloid malignancies treated with decitabine plus gemtuzumab ozogamicin.

Authors :: Short NJ
Richard-Carpentier G
Kanagal-Shamanna R
Patel KP
Konopleva M
Papageorgiou I
Pemmaraju N
Borthakur G
Ravandi F
DiNardo CD
Kadia TM
Kantarjian H
Lamba JK
Daver N
Source :: American journal of hematology [Am J Hematol] 2020 Sep; Vol. 95 (9), pp. E225-E228. Date of Electronic Publication: 2020 May 23.
Publication Year :: 2020

Subjects :: ATP Binding Cassette Transporter, Subfamily B genetics
Adult
Decitabine administration & dosage
Female
Gemtuzumab administration & dosage
Humans
Male
Antineoplastic Combined Chemotherapy Protocols administration & dosage
Hematologic Neoplasms drug therapy
Hematologic Neoplasms genetics
Hematologic Neoplasms mortality
Leukemia, Myeloid, Acute drug therapy
Leukemia, Myeloid, Acute genetics
Leukemia, Myeloid, Acute mortality
Neoplasm Proteins genetics
Polymorphism, Single Nucleotide
Sialic Acid Binding Ig-like Lectin 3 genetics

Full Text Access

Tools